BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29897458)

  • 1. Increased AIF-1-mediated TNF-α expression during implantation phase in IVF cycles with GnRH antagonist protocol.
    Xu B; Zhou M; Wang J; Zhang D; Guo F; Si C; Leung PCK; Zhang A
    Hum Reprod; 2018 Jul; 33(7):1270-1280. PubMed ID: 29897458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased PECAM1-mediated TGF-β1 expression in the mid-secretory endometrium in women with recurrent implantation failure.
    Guo F; Si C; Zhou M; Wang J; Zhang D; Leung PCK; Xu B; Zhang A
    Hum Reprod; 2018 May; 33(5):832-843. PubMed ID: 29617817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.
    Xu B; Geerts D; Hu S; Yue J; Li Z; Zhu G; Jin L
    Hum Reprod; 2020 Jun; 35(6):1306-1318. PubMed ID: 32478400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602 IVF/ICSI cycles.
    Thomsen LH; Kesmodel US; Erb K; Bungum L; Pedersen D; Hauge B; Elbæk HO; Povlsen BB; Andersen CY; Humaidan P
    Hum Reprod; 2018 Aug; 33(8):1506-1516. PubMed ID: 29955789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
    Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H
    Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial.
    Hamdine O; Macklon NS; Eijkemans MJ; Laven JS; Cohlen BJ; Verhoeff A; van Dop PA; Bernardus RE; Lambalk CB; Oosterhuis GJ; Holleboom CA; van den Dool-Maasland GC; Verburg HJ; van der Heijden PF; Blankhart A; Fauser BC; Broekmans FJ;
    Hum Reprod; 2013 Dec; 28(12):3227-35. PubMed ID: 24129613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced homeobox protein MSX1 in human endometrial tissue is linked to infertility.
    Bolnick AD; Bolnick JM; Kilburn BA; Stewart T; Oakes J; Rodriguez-Kovacs J; Kohan-Ghadr HR; Dai J; Diamond MP; Hirota Y; Drewlo S; Dey SK; Armant DR;
    Hum Reprod; 2016 Sep; 31(9):2042-50. PubMed ID: 27312535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocalyxin is a key negative regulator of human endometrial epithelial receptivity for embryo implantation.
    Paule SG; Heng S; Samarajeewa N; Li Y; Mansilla M; Webb AI; Nebl T; Young SL; Lessey BA; Hull ML; Scelwyn M; Lim R; Vollenhoven B; Rombauts LJ; Nie G
    Hum Reprod; 2021 Apr; 36(5):1353-1366. PubMed ID: 33822049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteal granulosa cells from natural cycles are more capable of maintaining their viability, steroidogenic activity and LH receptor expression than those of stimulated IVF cycles.
    Bildik G; Akin N; Seyhan A; Esmaeilian Y; Yakin K; Keles I; Balaban B; Ata B; Urman B; Oktem O
    Hum Reprod; 2019 Feb; 34(2):345-355. PubMed ID: 30520979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial HLA-F expression is influenced by genotypes and correlates differently with immune cell infiltration in IVF and recurrent implantation failure patients.
    Papúchová H; Saxtorph MH; Hallager T; Jepsen IE; Eriksen JO; Persson G; Funck T; Weisdorf I; Macklon NS; Larsen LG; Hviid TVF
    Hum Reprod; 2022 Jul; 37(8):1816-1834. PubMed ID: 35689445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of blastocyst euploidy rates following luteal versus follicular phase stimulation in a GnRH antagonist protocol: a prospective study with repeated ovarian stimulation cycles.
    Martinez F; Clua E; Roca M; Garcia S; Polyzos NP
    Hum Reprod; 2022 Nov; 37(12):2777-2786. PubMed ID: 36269092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine fluid microRNAs are dysregulated in women with recurrent implantation failure.
    von Grothusen C; Frisendahl C; Modhukur V; Lalitkumar PG; Peters M; Faridani OR; Salumets A; Boggavarapu NR; Gemzell-Danielsson K
    Hum Reprod; 2022 Apr; 37(4):734-746. PubMed ID: 35147192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of S100P induces apoptosis in endometrial epithelial cell during GnRH antagonist protocol.
    Zhang D; Han M; Zhou M; Liu M; Li Y; Xu B; Zhang A
    Reprod Biol Endocrinol; 2021 Jul; 19(1):99. PubMed ID: 34215278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled ovarian hyperstimulation for in vitro fertilization alters endometrial receptivity in humans: protocol effects.
    Haouzi D; Assou S; Dechanet C; Anahory T; Dechaud H; De Vos J; Hamamah S
    Biol Reprod; 2010 Apr; 82(4):679-86. PubMed ID: 20042535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the role of PGRMC2 in the human endometrium during the menstrual cycle and in vitro decidualization using an in vitro approach.
    Medina-Laver Y; Gonzalez-Martin R; de Castro P; Diaz-Hernandez I; Alama P; Quiñonero A; Palomar A; Dominguez F
    Hum Reprod; 2024 May; 39(5):1042-1056. PubMed ID: 38452349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound diagnosed adenomyosis has a negative impact on successful implantation following GnRH antagonist IVF treatment.
    Thalluri V; Tremellen KP
    Hum Reprod; 2012 Dec; 27(12):3487-92. PubMed ID: 22997247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.
    König TE; van der Houwen LE; Overbeek A; Hendriks ML; Beutler-Beemsterboer SN; Kuchenbecker WK; Renckens CN; Bernardus RE; Schats R; Homburg R; Hompes PG; Lambalk CB
    Hum Reprod; 2013 Oct; 28(10):2804-12. PubMed ID: 23838159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.